Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthequity (HQY) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Healthequity (HQY) over the last 12 years, with Q4 2025 value amounting to $14.0 million.

  • Healthequity's Interest Expenses fell 2261.64% to $14.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $59.1 million, marking a year-over-year increase of 17.11%. This contributed to the annual value of $60.6 million for FY2025, which is 933.91% up from last year.
  • Healthequity's Interest Expenses amounted to $14.0 million in Q4 2025, which was down 2261.64% from $15.0 million recorded in Q3 2025.
  • In the past 5 years, Healthequity's Interest Expenses ranged from a high of $18.2 million in Q4 2024 and a low of $6.7 million during Q2 2021
  • For the 5-year period, Healthequity's Interest Expenses averaged around $12.6 million, with its median value being $13.4 million (2023).
  • Examining YoY changes over the last 5 years, Healthequity's Interest Expenses showed a top increase of 7090.05% in 2021 and a maximum decrease of 5303.46% in 2021.
  • Over the past 5 years, Healthequity's Interest Expenses (Quarter) stood at $11.9 million in 2021, then rose by 2.39% to $12.2 million in 2022, then increased by 11.34% to $13.5 million in 2023, then surged by 34.03% to $18.2 million in 2024, then decreased by 22.62% to $14.0 million in 2025.
  • Its last three reported values are $14.0 million in Q4 2025, $15.0 million for Q3 2025, and $14.9 million during Q2 2025.